ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

NACompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Bone MetastasesMultiple Myeloma
Interventions
DEVICE

ExAblate MRfFUS

MR guided focused ultrasound.

DEVICE

Sham

sham comparator

Trial Locations (14)

10065

Weill Cornell Medical College, New York

19111

Fox Chase Cancer Center, Philadelphia

22908

University of Virginia Health System, Charlottesville

31096

Rambam medical Center -The Pain palliation unit, Haifa

33431

University MRI & Diagnostic Imaging Centers, Boca Raton

33612

Moffitt Cancer Center, Tampa

52621

Sheba Medical Center, Tel Litwinsky

197758

N. N. Petrov Institute of Oncology, Saint Petersburg

344037

Rostov State Research Institute of Oncology, Rostov-on-Don

92093-0987

University of California San Diego, La Jolla

94305-5642

Stanford University Medical Center, Stanford

02115

Brigham and Women's Hospital, Boston

M5G 2C4

Toronto General Hospital, Toronto

00161

"University of Rome La Sapienza", Rome

Sponsors

Lead Sponsor

All Listed Sponsors
lead

InSightec

INDUSTRY

NCT00656305 - ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain | Biotech Hunter | Biotech Hunter